TickerFacts.

Company research / RMTG

Regenerative Medical Technology Group Inc. (RMTG)

Build a valuation ↗↓ Download CSV

CIK 0001760026 · OTC · Retail-Retail Stores, NEC

  • Sector Retail Trade
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Regenerative Medical Technology Group Inc. reported revenue of $5.10M. Revenue grew 24.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

55.1%
Gross margin
-17.0%
Operating margin
-153.2%
Net margin
24.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-25

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$5.10M$4.11M$2.41M$1.53M$437.9K$55.1K$30.1K$50.1K$29.2K—
Cost of Revenue$2.29M$1.28M$734.3K$653.3K$287.8K$44.0K$55.5K$68.3K$4.8K—
Gross Profit$2.81M$2.82M$1.68M$877.0K$150.1K$11.1K-$25.4K-$18.2K$24.4K—
Operating Income-$867.2K$81.2K-$715.2K———————
Net Income-$7.81M-$5.56M-$9.81M-$5.51M-$12.88M-$5.90M-$2.51M-$2.06M-$377.0K—
EPS (Diluted)$-0.62$-0.44$-0.79$-0.45$-1.12—————
Total Assets$4.49M$3.82M$2.88M$8.08M$9.31M$219.7K$26.4K$34.6K$7.9K—
Total Liabilities$39.23M$31.18M$24.67M$20.06M$16.06M$6.55M$7.30M$4.57M$2.57M—
Shareholders' Equity-$34.75M-$27.36M-$21.80M-$11.98M-$6.76M-$6.41M-$7.36M-$4.54M-$2.56M-$5.51M
Cash & Equivalents$956.7K$1.17M$530.5K$1.65M$2.98M$42.5K$23.4K$30.8K$7.8K$6.6K
Operating Cash Flow-$706.5K$850.7K-$419.2K-$1.11M-$9.88M-$322.7K-$362.3K-$244.6K-$6.1K—
Capital Expenditures$602.6K$215.4K$385.6K$198.4K———$4.0K——
Shares Outstanding13.14M12.54M12.49M12.44M12.09M10.87M7.96M4.90M3.74M—
Weighted Average Diluted Shares12.63M12.53M12.45M12.22M11.48M—————
EPS (Basic)$-0.62$-0.44$-0.79$-0.45$-1.12$-0.63$-0.47$-0.50——